Pharming Group N.V. ( PHAR) - Key Metrics
PHAR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.29 | $0.02 | -$0.18 | -$0.18 |
| 2026Q1 | $1.03 | -$0.07 | $0.03 | $0.02 |
| 2025Q4 | $1.61 | $0.08 | $0.16 | $0.16 |
| 2025Q3 | $1.45 | $0.11 | $0.48 | $0.48 |
| 2025Q2 | $1.39 | $0.07 | $0.18 | $0.17 |
PHAR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 150.98 |
| 2026Q1 | 0% | -55.47 |
| 2025Q4 | 0% | 55.22 |
| 2025Q3 | 0% | 32.08 |
| 2025Q2 | 0% | 38.18 |
PHAR
Price: $11.23
52 week price:
Earnings Per Share: 0.15 USD
P/E Ratio: 68.40
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 1500
Market Capitalization: 794.8 million